As part of our efforts to bring all of “Us” together to end Alzheimer’s, we convene a range of key stakeholders to bring their voices, expertise, and commitment to take on big issues. These stakeholders include CEOs of major companies, leaders of a broad range of Alzheimer’s and dementia organizations, and top industry representatives to develop ways to understand patient and caregiver perspectives and bring them to drug development and regulation.